Show simple item record

dc.contributor.authorCervantes-Amat, Marta 
dc.contributor.authorLopez-Abente, Gonzalo 
dc.contributor.authorAragones, Nuria 
dc.contributor.authorPollan-Santamaria, Marina 
dc.contributor.authorPastor-Barriuso, Roberto 
dc.contributor.authorPerez-Gomez, Beatriz 
dc.date.accessioned2017-09-04T16:28:51Z
dc.date.available2017-09-04T16:28:51Z
dc.date.issued2015-04-15
dc.identifier.citationBMC Cancer. 2015; 15:287.
dc.identifier.urihttp://hdl.handle.net/20.500.12105/4815
dc.description.abstractBACKGROUND: In Spain, cervical cancer prevention is based on opportunistic screening, due to the disease's traditionally low incidence and mortality rates. Changes in sexual behaviour, tourism and migration have, however, modified the probability of exposure to human papilloma virus among Spaniards. This study thus sought to evaluate recent cervical cancer mortality trends in Spain. METHODS: We used annual female population figures and individual records of deaths certified as cancer of cervix, reclassifying deaths recorded as unspecified uterine cancer to correct coding quality problems. Joinpoint models were fitted to estimate change points in trends, as well as the annual (APC) and average annual percentage change. Log-linear Poisson models were also used to study age-period-cohort effects on mortality trends and their change points. RESULTS: 1981 marked the beginning of a decline in cervical cancer mortality (APC(1981-2003): -3.2; 95% CI:-3.4;-3.0) that ended in 2003, with rates reaching a plateau in the last decade (APC2003-2012: 0.1; 95% CI:-0.9; 1.2). This trend, which was observable among women aged 45-46 years (APC(2003-2012): 1.4; 95% CI:-0.1;2.9) and over 65 years (APC(2003-2012): -0.1; 95% CI:-1.9;1.7), was clearest in Spain's Mediterranean and Southern regions. CONCLUSIONS: The positive influence of opportunistic screening is not strong enough to further reduce cervical cancer mortality rates in the country. Our results suggest that the Spanish Health Authorities should reform current prevention programmes and surveillance strategies in order to confront the challenges posed by cervical cancer.
dc.description.sponsorshipThis study was supported by a research grant from the Spanish Health Research Fund [FIS PI11/00871]. Mortality data were furnished by the Spanish National Statistics Institute under the terms of a specific confidentially protocol
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isversionofPublisher's version
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectUterine cervical neoplasms
dc.subjectMortality rate
dc.subjectSpain
dc.subjectTrends
dc.titleThe end of the decline in cervical cancer mortality in Spain: trends across the period 1981–2012
dc.typeArtículo
dc.rights.licenseAtribución 3.0 España*
dc.format.volume15
dc.format.number1
dc.format.page287
dc.identifier.doi10.1186/s12885-015-1306-x
dc.contributor.funderInstituto de Salud Carlos III - ISCIII
dc.description.peerreviewed
dc.identifier.e-issn1471-2407
dc.relation.publisherversionhttps://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-1306-x
dc.identifier.journalBMC Cancer
dc.repisalud.centroISCIII::Centro Nacional de Epidemología::Área de Epidemiología Ambiental y Cáncer
dc.repisalud.institucionISCIII
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 3.0 España
This item is licensed under a: Atribución 3.0 España